{"id":"https://openalex.org/W2410530516","doi":null,"title":"Changes in carbamazepine plasma concentrations in psychiatric patients during treatment.","display_name":"Changes in carbamazepine plasma concentrations in psychiatric patients during treatment.","publication_year":1991,"publication_date":"1991-11-01","ids":{"openalex":"https://openalex.org/W2410530516","mag":"2410530516","pmid":"https://pubmed.ncbi.nlm.nih.gov/1821043"},"language":"en","primary_location":{"id":"pmid:1821043","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1821043","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology and pharmacy","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053118739","display_name":"Roman Kanarkowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Kanarkowski","raw_affiliation_strings":["Department of Biopharmaceutics, Medical Centre of Postgraduate Education, Bydgoszcz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biopharmaceutics, Medical Centre of Postgraduate Education, Bydgoszcz, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001537697","display_name":"JANUSZ K. RYBAKOWSKI","orcid":"https://orcid.org/0000-0003-0577-0381","observed_orcids":["https://orcid.org/0000-0003-0577-0381"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Rybakowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"W Lehmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Lehmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5003315608","display_name":"K Matkowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Matkowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.28084016,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"6","first_page":"479","last_page":"85"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.6636000275611877,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.6636000275611877,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2800000011920929,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":1.0},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.7110000252723694},{"id":"https://openalex.org/keywords/psychiatric-patients","display_name":"psychiatric patients","score":0.7269999980926514},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.6959999799728394},{"id":"https://openalex.org/keywords/steady-state-concentration","display_name":"steady-state concentration","score":0.652999997138977},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6790000200271606},{"id":"https://openalex.org/keywords/psychotropic-drug-interactions","display_name":"psychotropic drug interactions","score":0.5699999928474426},{"id":"https://openalex.org/keywords/anticonvulsant-therapy","display_name":"anticonvulsant therapy","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.9236737489700317},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7135316133499146},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.6595693826675415},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5411824584007263},{"id":"https://openalex.org/C27924281","wikidata":"https://www.wikidata.org/wiki/Q17126475","display_name":"Maintenance dose","level":2,"score":0.517271101474762},{"id":"https://openalex.org/C3017575891","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma levels","level":2,"score":0.48051226139068604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44118085503578186},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4320402443408966},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3534508943557739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23959720134735107},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1425875723361969},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.13895314931869507}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:1821043","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1821043","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology and pharmacy","raw_type":"Journal Article"},{"id":"mag:2410530516","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1821043","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2397053509","https://openalex.org/W4235060474","https://openalex.org/W1978984927","https://openalex.org/W205469118","https://openalex.org/W1972383976","https://openalex.org/W1964465959","https://openalex.org/W1969160909","https://openalex.org/W2029783232","https://openalex.org/W2405851740","https://openalex.org/W2417485045"],"abstract_inverted_index":{"Plasma":[0],"concentrations":[1,44],"of":[2,16,35,50,74,86,95,153,155,172,176],"carbamazepine":[3],"(CBZ)":[4],"were":[5,12,23,100],"studied":[6],"in":[7,105,111,113],"24":[8],"psychiatric":[9],"patients":[10,106,112],"who":[11],"given":[13],"400":[14],"mg":[15],"CBZ":[17,43,64,87,97,108,115,130,146,166,177],"every":[18],"12":[19],"h.":[20],"The":[21,38,63],"assays":[22],"performed":[24],"on":[25,46],"the":[26,36,47,56,71,83,91,128,134,156,160,164,170,173],"1st,":[27],"3rd,":[28],"8th,":[29],"15th,":[30],"22th":[31],"and":[32,59,76,137,163],"29th":[33],"day":[34,49,58,73],"therapy.":[37,96,178],"highest":[39],"minimum":[40,129],"12h":[41],"plasma":[42,98,131],"occurred":[45],"3rd":[48],"therapy,":[51],"then":[52,77],"decreased":[53],"up":[54,69],"to":[55,70,118],"15th":[57,72],"remained":[60],"stable":[61],"thereafter.":[62],"half-time":[65],"values":[66],"also":[67],"diminished":[68],"therapy":[75],"stabilized.":[78],"This":[79],"may":[80],"suggest":[81],"that":[82,138],"enzymatic":[84],"autoinduction":[85],"is":[88],"completed":[89],"within":[90],"first":[92,135,161],"1-2":[93],"weeks":[94],"levels":[99],"slightly":[101],"but":[102],"insignificantly":[103],"higher":[104],"taking":[107],"alone":[109],"than":[110],"which":[114],"was":[116,125],"added":[117],"other":[119],"psychotropic":[120],"drugs.":[121],"A":[122,142],"significant":[123],"correlation":[124],"found":[126],"between":[127],"concentration":[132],"after":[133],"dose":[136,158,168],"at":[139],"steady":[140],"state.":[141],"dosing":[143],"schedule":[144],"for":[145],"administration":[147,152],"has":[148],"been":[149],"proposed":[150],"with":[151],"75%":[154],"maintenance":[157,167],"during":[159],"week":[162,175],"full":[165],"from":[169],"beginning":[171],"second":[174]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}